Bifogade filer
PDF
Kurs
0,00%
Kalender
| Est. tid* | ||
| 2022-01-26 | - | Bokslutskommuniké 2021 |
| 2021-07-14 | - | Kvartalsrapport 2021-Q2 |
| 2021-06-30 | - | Årsstämma |
| 2021-05-27 | - | X-dag ordinarie utdelning NATTO 0.00 NOK |
| 2021-02-17 | - | Bokslutskommuniké 2020 |
| 2020-11-11 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-15 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-22 | - | X-dag ordinarie utdelning NATTO 0.00 NOK |
| 2020-06-19 | - | Årsstämma |
| 2020-05-06 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-19 | - | Bokslutskommuniké 2019 |
| 2019-11-13 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-21 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-31 | - | X-dag ordinarie utdelning NATTO 0.00 NOK |
| 2019-05-29 | - | Årsstämma |
| 2019-04-30 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-13 | - | Bokslutskommuniké 2018 |
| 2018-08-22 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-31 | - | X-dag ordinarie utdelning NATTO 0.00 NOK |
| 2018-05-30 | - | Årsstämma |
| 2018-02-08 | - | Bokslutskommuniké 2017 |
| 2017-11-24 | - | Extra Bolagsstämma 2017 |
| 2017-08-16 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-16 | - | X-dag ordinarie utdelning NATTO 0.00 NOK |
| 2017-05-15 | - | Årsstämma |
| 2017-05-15 | - | Kapitalmarknadsdag 2017 |
| 2017-05-15 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-08 | - | Bokslutskommuniké 2016 |
| 2016-11-16 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-17 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-20 | - | Årsstämma |
| 2016-05-20 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-26 | - | Bokslutskommuniké 2015 |
| 2015-11-25 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-26 | - | Kvartalsrapport 2015-Q2 |
| 2014-11-26 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-27 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-27 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-17 | - | Bokslutskommuniké 2013 |
| 2013-11-26 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-27 | - | Kvartalsrapport 2013-Q2 |
| 2013-05-22 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-28 | - | Bokslutskommuniké 2012 |
| 2012-11-15 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-21 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-16 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-28 | - | Bokslutskommuniké 2011 |
| 2012-02-13 | - | Extra Bolagsstämma 2012 |
| 2011-11-17 | - | Kvartalsrapport 2011-Q3 |
| 2011-10-31 | - | Extra Bolagsstämma 2011 |
| 2011-08-18 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-19 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-25 | - | Bokslutskommuniké 2010 |
Beskrivning
| Land | Norge |
|---|---|
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Oslo, Norway (29 March 2021) -
Reference is made to the offer document dated 8 March 2021 (the "Offer Document") for the recommended voluntary offer by Compagnie des Levures Lesaffre (the "Offeror") to acquire all outstanding shares in NattoPharma ASA ("NattoPharma" or the "Company") against a consideration in cash of NOK 35 per share (the "Offer"), and further reference is made to the stock exchange announcement dated 23 March 2021 in which the Offeror announced that the closing conditions "Minimum Acceptance" and "Regulatory Approval" are considered to be fulfilled.
All of the Company's option holders, representing all of the outstanding 1,200,850 options in the Company (the "Company Options"), have irrevocably committed to exercise the Company Options to subscribe for Shares in the Company and to sell such Shares to the Offeror on the same terms and conditions as the Offer.
Based on the authorization granted at the annual general meeting of NattoPharma on June 19, 2020, the Board of Directors of NattoPharma has therefore resolved a share issue of 1,200,850 new shares, each with a nominal value of NOK 3 per share.
The share capital increase has been registered and the Company's new share capital is NOK 63,132,849 divided into 21,044,283 registered shares each with a nominal value of NOK 3.00.
***
For more information, please contact:
Robert Schrama, CFO
E-mail: robert.schrama@nattopharma.com
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities